Stellate DNA develops proprietary DNA donor technology that is used to synthesize and produce single-strand DNA donors.
Stellate DNA has raised $256K in total funding. The most recent round was Grant. The last funding was announced in July 2021.
Stellate DNA's investors include National Science Foundation.
Stellate DNA is headquartered in Cambridge, United States.
Stellate DNA develops proprietary DNA donor technology that is used to synthesize and produce single-strand DNA donors.
Stellate DNA is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stellate DNA — Funding & Investors." VCBacked, July 15, 2021, https://www.vcbacked.co/company/stellate-dna. Accessed August 14, 2026.
VCBacked. (2021). Stellate DNA — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/stellate-dna
{{cite web |title=Stellate DNA — Funding & Investors |url=https://www.vcbacked.co/company/stellate-dna |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated